In prostate cancer, overexpression of Male Germ Cell-Associated Kinase (MAK), a male-specific kinase and co-activator of androgen receptor leads to increased expression level of GINS2 by mRNA profiling [23]. The gene discussed is GINS2; the disease is prostate carcinoma.